Mounjaro and Other Medications Mounjaro can influence the absorption and effectiveness of other drugs, primarily due to its effect on slowing gastric emptying
The Medications Prescribed by Mochi Health Mochi Health specializes in GLP-1 (Glucagon-Like Peptide-1) and GIP receptor agonists
Supportive secondary endpoints included change from baseline to week 26 in FPG, 7-point SMPG, body weight (%), BMI, waist circumference and fasting lipid profile
Because millions of people are already taking GLP-1s for health conditions like diabetes, obesity, and cardiovascular disease, with more indications in progress, there are millions of people who will reduce their substance use simply as an unexpected, and maybe even unnoticed, side effect of the medications, as well as millions more who will avoid developing addictions or unhealthy substance use patterns in the first place